| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.072 | 0.2 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |